{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T21:48:18Z","timestamp":1764193698238},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.ijantimicag.2006.04.012","type":"journal-article","created":{"date-parts":[[2006,8,15]],"date-time":"2006-08-15T08:27:48Z","timestamp":1155630468000},"page":"221-225","source":"Crossref","is-referenced-by-count":6,"title":["Liver tissue concentrations of levofloxacin after single intravenous administration of 500mg for antibiotic prophylaxis in liver surgery"],"prefix":"10.1016","volume":"28","author":[{"given":"Malte","family":"Weinrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Scheingraber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Stremovskaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin K.","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frieder","family":"Kees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg A.","family":"Pistorius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2006.04.012_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003495-199957010-00007","article-title":"Biliary tract infections \u2014 a guide to drug treatment","volume":"57","author":"Westphal","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2006.04.012_bib2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/jac\/dgk056","article-title":"Tissue and serum concentrations of levofloxacin 500mg administered intravenously or orally for antibiotic prophylaxis in biliary surgery","volume":"51","author":"Swoboda","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.04.012_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0924-8579(00)00192-8","article-title":"The fluoroquinolone antibacterials: past, present and future perspectives","volume":"16","author":"Appelbaum","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2006.04.012_bib4","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1345\/aph.10182","article-title":"Is more than one quinolone needed in clinical practice?","volume":"35","author":"Paladino","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2006.04.012_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00003088-200140030-00003","article-title":"Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials","volume":"40","author":"Aminimanizani","year":"2001","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2006.04.012_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000057841","article-title":"Evidence of different profiles of side effects and drug\u2013drug interactions among the quinolones \u2014 the pharmacokinetic standpoint","volume":"47","author":"Lode","year":"2001","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2006.04.012_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00003088-199732020-00002","article-title":"The clinical pharmacokinetics of levofloxacin","volume":"32","author":"Fish","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2006.04.012_bib8","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1128\/AAC.44.10.2600-2603.2000","article-title":"Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin and moxifloxacin after single oral administration in healthy volunteers","volume":"44","author":"Lubasch","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.04.012_bib9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1159\/000238605","article-title":"Penetration of fleroxacin into prostatic secretion and prostatic adenoma tissue","volume":"34","author":"Kees","year":"1988","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2006.04.012_bib10","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijantimicag.2006.04.012_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijantimicag.2005.09.014","article-title":"Pharmacokinetics of ciprofloxacin XR (1000mg) versus levofloxacin (500mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose","volume":"27","author":"Wagenlehner","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2006.04.012_bib12","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1128\/AAC.42.8.2048","article-title":"Pharmacokinetics of [18F]trovafloxacin in healthy human subjects studied with positron emission tomography","volume":"42","author":"Fischman","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.04.012_bib13","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1128\/AAC.37.10.2144","article-title":"Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography","volume":"37","author":"Fischman","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.04.012_bib14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/oxfordjournals.jac.a002697","article-title":"Tissue penetration of a single dose of levofloxacin intravenously for antibiotic prophylaxis in lung surgery","volume":"47","author":"Von Baum","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. A","key":"10.1016\/j.ijantimicag.2006.04.012_bib15","first-page":"104","article-title":"Levofloxacin prevented liver abscess and supportive cholecystitis following transcatheter arterial embolization for hepatocellular carcinoma","volume":"44","author":"Nomura","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.04.012_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0924-8579(02)00024-9","article-title":"Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations","volume":"19","author":"Liu","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2006.04.012_bib17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2165\/00003088-200241100-00004","article-title":"Clinical role of protein binding of quinolones","volume":"41","author":"Bergogne-B\u00e9r\u00e9zin","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2006.04.012_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/jac\/45.4.483","article-title":"Levofloxacin penetrates human monocytes and enhances intracellular killing of Staphylococcus aureus and Pseudomonas aeruginosa","volume":"45","author":"Smith","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.04.012_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2003-36676","article-title":"Ceftriaxone versus levofloxacin for antibiotic therapy in patients with acute cholangitis","volume":"41","author":"Kie\u00dflich","year":"2003","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.ijantimicag.2006.04.012_bib20","unstructured":"Lee WJ, Che YS, Lee JH, Kim KS, Kim BY. Clinical efficacy and safety of intravenous levofloxacin in patients of abdominal operation. In: Program and Abstracts of the 10th International Congress on Infectious Diseases; Singapore, Malaysia; 2002 March 11\u201314."},{"key":"10.1016\/j.ijantimicag.2006.04.012_bib21","unstructured":"Calza L, Manfredi R, Marinacci G, Fortunato L, Chiodo F. Liver abscess caused by Stenotrophomonas (Xanthomonas) maltophilia in a patient with acquired immunodeficiency syndrome. In: Program and Abstracts of the 10th International Congress on Infectious Diseases; Singapore, Malaysia; 2002 March 11\u201314."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857906002226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857906002226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T13:53:48Z","timestamp":1555768428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857906002226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0924857906002226"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2006.04.012","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}